Our Take On Kamada Ltd (KMDA)’s Upcoming Catalysts

So we just learnt that development stage biotech company Kamada Ltd (NASDAQ:KMDA) is set to put out topline from a phase II in antitrypsin deficiency before the end of this quarter...

Keep Reading →